human | Q5 |
P6178 | Dimensions author ID | 01153074347.67 |
P2798 | Loop ID | 376373 |
P3835 | Mendeley person ID | sandro-esteves |
P496 | ORCID iD | 0000-0002-1313-9680 |
P3829 | Publons author ID | 1183119 |
P1053 | ResearcherID | G-4416-2012 |
P1153 | Scopus author ID | 57208580149 |
6701810934 |
P734 | family name | Esteves | Q17496678 |
Esteves | Q17496678 | ||
Esteves | Q17496678 | ||
P735 | given name | Sandro | Q2221177 |
Sandro | Q2221177 | ||
P106 | occupation | researcher | Q1650915 |
P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
P21 | sex or gender | male | Q6581097 |
Q64087509 | A Novel Predictive Model to Estimate the Number of Mature Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing Fertilization/Intracytoplasmic Sperm Injection: The ART Calculator |
Q42655889 | A Strengths-Weaknesses-Opportunities-Threats (SWOT) analysis on the clinical utility of sperm DNA fragmentation testing in specific male infertility scenarios. |
Q38172104 | A clinical appraisal of the genetic basis in unexplained male infertility. |
Q35585425 | A critical appraisal on the role of varicocele in male infertility. |
Q48556571 | A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept |
Q41478820 | A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study |
Q91184062 | A quality management approach to controlled ovarian stimulation in assisted reproductive technology: the "Fischer protocol" |
Q42693419 | A single cut-off value of sperm DNA fragmentation testing does not fit all. |
Q36628757 | A systematic review of clinical practice guidelines and best practice statements for the diagnosis and management of varicocele in children and adolescents |
Q38560096 | A systematic review of recent clinical practice guidelines and best practice statements for the evaluation of the infertile male |
Q38207554 | A translational medicine appraisal of specialized andrology testing in unexplained male infertility. |
Q46546106 | Abstinence Time and Its Impact on Basic and Advanced Semen Parameters |
Q36628779 | Afterword to varicocele and male infertility: current concepts and future perspectives. |
Q37113186 | Air quality control in the ART laboratory is a major determinant of IVF success |
Q42693819 | All-round approach in diagnosis. |
Q42693459 | An evidence-based perspective on the role of sperm chromatin integrity and sperm DNA fragmentation testing in male infertility. |
Q91138106 | An update on clinical and surgical interventions to reduce sperm DNA fragmentation in infertile men |
Q34978804 | An update on the clinical assessment of the infertile male. [corrected]. |
Q53981265 | Antegrade endopyelotomy for pelvi-ureteric junction obstruction in children. |
Q42693559 | Antioxidants for elevated sperm DNA fragmentation: a mini review |
Q92083801 | Are specialized sperm function tests clinically useful in planning assisted reproductive technology? |
Q50865965 | Ascorbic acid reduces redox potential in human spermatozoa subjected to heat-induced oxidative stress. |
Q54958781 | Association Between Progesterone Elevation on the Day of Human Chronic Gonadotropin Trigger and Pregnancy Outcomes After Fresh Embryo Transfer in In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles. |
Q46293230 | Association between promoter methylation of MLH1 and MSH2 and reactive oxygen species in oligozoospermic men-A pilot study |
Q87854339 | Author Reply |
Q42693170 | Best practice statements are not intended to dictate an exclusive course of management |
Q28072600 | Bibliometrics: tracking research impact by selecting the appropriate metrics |
Q94668982 | COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management |
Q42693646 | Call for wider application of sperm DNA fragmentation test |
Q50958206 | Characterisation of a subpopulation of sperm with massive nuclear damage, as recognised with the sperm chromatin dispersion test. |
Q38817257 | Cigarette Smoking and Semen Quality: A New Meta-analysis Examining the Effect of the 2010 World Health Organization Laboratory Methods for the Examination of Human Semen. |
Q28083691 | Clinical management of infertile men with nonobstructive azoospermia |
Q45359268 | Clinical outcome of intracytoplasmic sperm injection in infertile men with treated and untreated clinical varicocele |
Q89165748 | Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis |
Q27030763 | Clinical relevance of routine semen analysis and controversies surrounding the 2010 World Health Organization criteria for semen examination |
Q91465309 | Clinical utility of freeze-all approach in ART treatment: A mini-review |
Q93123805 | Clinical utility of sperm DNA damage in male infertility |
Q42693741 | Clinical utility of sperm DNA fragmentation testing: concise practice recommendations |
Q37531089 | Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios |
Q68331218 | Comparative study of the fertility potential of men with only one testis |
Q48568150 | Comparison of reproductive outcome in oligozoospermic men with high sperm DNA fragmentation undergoing intracytoplasmic sperm injection with ejaculated and testicular sperm |
Q33922425 | Comparison of sperm retrieval and reproductive outcome in azoospermic men with testicular failure and obstructive azoospermia treated for infertility. |
Q42693299 | Comparison of strategies to reduce sperm DNA fragmentation in couples undergoing ICSI |
Q64095496 | Correction to: The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis |
Q37954458 | Critical appraisal of World Health Organization's new reference values for human semen characteristics and effect on diagnosis and treatment of subfertile men. |
Q42693399 | Current limitation and future perspective of sperm DNA fragmentation tests |
Q58769667 | Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why |
Q42693568 | Despite limitations, sperm DNA fragmentation testing provides unique information complementary to but distinct from semen analysis results. |
Q42693335 | Development of targeted therapeutic strategies and refinement of sperm DNA fragmentation testing |
Q42693100 | Development of treatment strategies in men with vulnerable sperm. |
Q37839640 | Diagnostic accuracy of sperm DNA degradation index (DDSi) as a potential noninvasive biomarker to identify men with varicocele-associated infertility |
Q44721443 | Diagnostic accuracy of sperm chromatin dispersion test to evaluate sperm deoxyribonucleic acid damage in men with unexplained infertility |
Q42693198 | Drawbacks of the current practice |
Q42382519 | Editorial - A missing vas deferens: practical implications for urologists performing vasectomies and managing infertile men |
Q41412099 | Editorial Comment: Antioxidant enzyme profile and lipid peroxidation products in semen samples of testicular germ cell tumor patients submitted to orchiectomy |
Q94915024 | Editorial comment |
Q94998272 | Editorial comment |
Q95524052 | Editorial comment |
Q94432727 | Effect of cigarette smoking on levels of seminal oxidative stress in infertile men: a prospective study |
Q36899932 | Effect of in vitro incubation on spontaneous acrosome reaction in fresh and cryopreserved human spermatozoa. |
Q38220066 | Effect of mobile telephones on sperm quality: a systematic review and meta-analysis |
Q73227005 | Effect of swim-up sperm washing and subsequent capacitation on acrosome status and functional membrane integrity of normal sperm |
Q28068085 | Effect of varicocele on semen characteristics according to the new 2010 World Health Organization criteria: a systematic review and meta-analysis |
Q88063273 | Effect of varicocele repair on sperm DNA fragmentation: a review |
Q45298260 | Effects of the technique of cryopreservation and dilution/centrifugation after thawing on the motility and vitality of spermatozoa of oligoasthenozoospermic men. |
Q42693547 | Elucidating the clinical indications of sperm DNA fragmentation in male infertility |
Q35396244 | Engaging practicing gynecologists in the management of infertile men. |
Q89371882 | Estimation of age-dependent decrease in blastocyst euploidy by next generation sequencing: development of a novel prediction model |
Q33290656 | Evaluation of acrosomal status and sperm viability in fresh and cryopreserved specimens by the use of fluorescent peanut agglutinin lectin in conjunction with hypo-osmotic swelling test |
Q42693755 | Expanding our understanding of clinical laboratory testing in male infertility patients. |
Q42693696 | Expanding treatment paradigm of high sperm DNA fragmentation. |
Q91869810 | Extended indications for sperm retrieval: summary of current literature |
Q81304244 | Feasibility of refreezing human spermatozoa through the technique of liquid nitrogen vapor |
Q91184058 | Female infertility and assisted reproductive technology |
Q89371874 | Freeze-all strategy in IVF/ICSI cycles: an update on clinical utility |
Q58616365 | Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes |
Q95566182 | Fresh versus frozen blastocyst transfer |
Q42693630 | From bench to clinic |
Q42693555 | Frontiers in clinical andrology. |
Q42693662 | Further evidence supports the clinical utility of sperm DNA fragmentation testing in male infertility workup and assisted reproductive technology |
Q92238745 | Future Perspectives of POSEIDON Stratification for Clinical Practice and Research |
Q42693342 | Future direction in sperm DNA fragmentation testing. |
Q33770533 | GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis |
Q30796722 | Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech. |
Q91524801 | Hormonal stimulation of spermatogenesis: a new way to treat the infertile male with non-obstructive azoospermia? |
Q91184069 | Hot topics in female infertility: an afterword |
Q93123826 | Hot topics in male infertility: an afterword |
Q48282494 | Human sperm handling in intracytoplasmic sperm injection processes: In vitro studies on mouse oocyte activation, embryo development competence and sperm oxidation-reduction potential |
Q89371867 | Impact of Body Mass Index on female fertility and ART outcomes |
Q44253132 | Implementation of air quality control in reproductive laboratories in full compliance with the Brazilian Cells and Germinative Tissue Directive |
Q40279650 | Implementation of cleanroom technology in reproductive laboratories: the question is not why but how. |
Q42693667 | Implication of sperm processing during assisted reproduction on sperm DNA integrity. |
Q33181122 | Improvement in motion characteristics and acrosome status in cryopreserved human spermatozoa by swim-up processing before freezing. |
Q93123810 | Indications and outcomes of varicocele repair |
Q52663984 | Individualized controlled ovarian stimulation in expected poor-responders: an update. |
Q48768364 | Influence of antisperm antibodies in the semen on intracytoplasmic sperm injection outcome |
Q48868695 | Influence of subacute starvation on cardiac response to isoproterenol in rats |
Q38061032 | Insight into oxidative stress in varicocele-associated male infertility: part 1. |
Q38061031 | Insight into oxidative stress in varicocele-associated male infertility: part 2. |
Q42693658 | Insights on the predictive accuracy of the sperm DNA fragmentation tests on male infertility. |
Q42693426 | Integrating surgical and clinical andrology is essential to improve the quality of care delivered to infertile couples. |
Q91844332 | Interventions to Prevent Sperm DNA Damage Effects on Reproduction |
Q89394173 | Intracytoplasmic sperm injection for male infertility and consequences for offspring |
Q42693139 | Is National Institute of Clinical Excellence (NICE) guideline a nice guideline? |
Q42693389 | It is high time for clinical application of sperm DNA fragmentation testing |
Q94432729 | Lack of standardization in performance of the semen analysis among laboratories in the United States |
Q42693084 | Live birth must be the primary reproductive endpoint in IVF/ICSI studies evaluating sperm DNA fragmentation testing. |
Q91967824 | Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility |
Q93123789 | Male infertility and assisted reproductive technology |
Q90400739 | Management Strategies for POSEIDON Groups 3 and 4 |
Q91971401 | Management of Women With an Unexpected Low Ovarian Response to Gonadotropin |
Q89371886 | Methods of surgical sperm extraction and implications for assisted reproductive technology success |
Q37186608 | Micro-dissection testicular sperm extraction as an alternative for sperm acquisition in the most difficult cases of Azoospermia: Technique and preliminary results in India |
Q44161336 | Microdissection testicular sperm extraction (micro-TESE) as a sperm acquisition method for men with nonobstructive azoospermia seeking fertility: operative and laboratory aspects |
Q42693092 | More good than harm should be expected when Testi-ICSI is applied to oligozoospermic men with post-testicular sperm DNA fragmentation. |
Q46405662 | Multi-centre assessment of nitroblue tetrazolium reactivity in human semen as a potential marker of oxidative stress. |
Q90318013 | Novel approaches for diagnosis and management of low prognosis patients in assisted reproductive technology: the POSEIDON concept |
Q38898947 | Novel concepts in male factor infertility: clinical and laboratory perspectives |
Q37850847 | Novel concepts in male infertility. |
Q28075386 | Novel insights into the pathophysiology of varicocele and its association with reactive oxygen species and sperm DNA fragmentation |
Q42693306 | One of the many missing links between infertility and sperm DNA fragmentation |
Q91396450 | Oocyte quantity, as well as oocyte quality, plays a significant role for the cumulative live birth rate of a POSEIDON criteria patient |
Q36628746 | Outcome of assisted reproductive technology in men with treated and untreated varicocele: systematic review and meta-analysis. |
Q36628741 | Outcome of varicocele repair in men with nonobstructive azoospermia: systematic review and meta-analysis |
Q30399240 | Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology. |
Q90318021 | Paternal age and assisted reproductive technology: problem solver or trouble maker? |
Q36589410 | Percutaneous epididymal sperm aspiration as a method for sperm retrieval in men with obstructive azoospermia seeking fertility: operative and laboratory aspects. |
Q37427014 | Persistent Mullerian Duct Syndrome: a rare entity with a rare presentation in need of multidisciplinary management. |
Q89146718 | Pharmacogenetic algorithm for individualized controlled ovarian stimulation in assisted reproductive technology cycles |
Q88215036 | Poor definition of poor-ovarian response results in misleading clinical recommendations |
Q81479449 | Predictive value of testicular histology in secretory azoospermic subgroups and clinical outcome after microinjection of fresh and frozen-thawed sperm and spermatids |
Q96233004 | Predictors of surgical sperm retrieval in non-obstructive azoospermia: summary of current literature |
Q36589271 | Pregnancy and birth after intracytoplasmic sperm injection with normal testicular spermatozoa in a patient with azoospermia and tail stump epididymal sperm |
Q91503205 | Protein supplementation intake for bodybuilding and resistance training may impact sperm quality of subfertile men undergoing fertility treatment: a pilot study |
Q51741136 | Proteomic Signatures of Sperm Mitochondria in Varicocele: Clinical Utility as Biomarkers of Varicocele-Associated Infertility. |
Q45906758 | REPLY BY THE AUTHORS: Re: Persistent Mullerian Duct Syndrome: a rare entity with a rare presentation in need of multidisciplinary management. |
Q45875785 | Re: Sperm retrieval rates and intracytoplasmic sperm injection outcomes for men with non-obstructive azoospermia and the health of resulting offspring. |
Q42693592 | Reactive oxygen species and sperm DNA fragmentation |
Q58088530 | Reactive oxygen species-induced alterations in H19-Igf2 methylation patterns, seminal plasma metabolites, and semen quality |
Q56391239 | Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review |
Q82136142 | Recovery of spermatogenesis after microsurgical subinguinal varicocele repair in azoospermic men based on testicular histology |
Q47428122 | Reply from Authors re: Christian Leiber, Ulrich Wetterauer. The Cigarette and the Sperm: A Fatal Liaison? Eur Urol 2016;70:646-7: The Cigarette and the Sperm: Causality Dilemma no more? |
Q87643274 | Reply to Eugenio Ventimiglia, Montorsi Francesco, and Andrea Salonia's Letter to the Editor re: Reecha Sharma, Avi Harlev, Ashok Agarwal, Sandro C. Esteves. Cigarette Smoking and Semen Quality: A New Meta-analysis Examining the Effect of the 2010 Wo |
Q48513891 | Reproductive outcomes of testicular versus ejaculated sperm for intracytoplasmic sperm injection among men with high levels of DNA fragmentation in semen: systematic review and meta-analysis |
Q30600775 | Reproductive outcomes, including neonatal data, following sperm injection in men with obstructive and nonobstructive azoospermia: case series and systematic review |
Q45182294 | Reproductive potential of men with obstructive azoospermia undergoing percutaneous sperm retrieval and intracytoplasmic sperm injection according to the cause of obstruction |
Q84792378 | Resistance of human spermatozoa to cryoinjury in repeated cycles of thaw-refreezing |
Q49642648 | Response: Nitroblue tetrazolium (NBT) assay |
Q42693748 | Restoration of fertility potential via targeted treatment approach |
Q42693736 | Risk factors associated with sperm DNA fragmentation. |
Q92111055 | Role of genetics and epigenetics in male infertility |
Q52648873 | Shedding light on the controversy surrounding the temporal decline in human sperm counts: a systematic review. |
Q89205874 | Should a Couple with Failed In Vitro Fertilization or Intracytoplasmic Sperm Injection and Elevated Sperm DNA Fragmentation Use Testicular Sperm for the Next Cycle? |
Q38800666 | Should we evaluate and treat sperm DNA fragmentation? |
Q28076207 | Specialized sperm function tests in varicocele and the future of andrology laboratory |
Q42693675 | Sperm DNA fragmentation for the evaluation of male infertility: clinical algorithms |
Q42693434 | Sperm DNA fragmentation in clinical practice. |
Q42693708 | Sperm DNA fragmentation test results reflect the overall quality of the whole semen specimen |
Q42693396 | Sperm DNA fragmentation testing in patients with subclinical varicocele: is there any evidence? |
Q42693527 | Sperm DNA fragmentation testing is on the right track. |
Q42693690 | Sperm DNA fragmentation testing is the safe and economical way to go. |
Q42693653 | Sperm DNA fragmentation testing reveals the overall quality of a semen sample. |
Q101240639 | Sperm DNA fragmentation testing: Summary evidence and clinical practice recommendations |
Q42693650 | Sperm DNA fragmentation testing: a cross sectional survey on current practices of fertility specialists. |
Q42693473 | Sperm DNA fragmentation: a key player in decision making. |
Q42693793 | Sperm DNA fragmentation: a rationale for its clinical utility |
Q42693174 | Sperm DNA fragmentation: laboratory and clinical aspects |
Q42693224 | Sperm DNA fragmentation: overcoming standardization obstacles |
Q94432724 | Sperm aneuploidy rates in younger and older men |
Q80874713 | Sperm defect severity rather than sperm Source is associated with lower fertilization rates after intracytoplasmic sperm injection |
Q37958213 | Sperm retrieval techniques for assisted reproduction. |
Q78067263 | Sperm viability assays--a matter of life and death! |
Q114632942 | Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology |
Q57821092 | Storage of sperm samples from males with azoospermia |
Q28079817 | Summary evidence on the effects of varicocele treatment to improve natural fertility in subfertile men |
Q42693291 | Technical aspects of sperm DNA fragmentation testing, methods to select sperm with low DNA fragmentation, and usefulness of redox potential measurement in male infertility. |
Q36594311 | Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay using bench top flow cytometer for evaluation of sperm DNA fragmentation in fertility laboratories: protocol, reference values, and quality control |
Q93123817 | Testicular sperm for intracytoplasmic sperm injection in non-azoospermic men: a paradigm shift |
Q64914201 | Testicular versus ejaculated sperm should be used for intracytoplasmic sperm injection (ICSI) in cases of infertility associated with sperm DNA fragmentation | Opinion: Yes. |
Q89135758 | The 'Big Freeze': freeze-all should not be used for everyone |
Q91868092 | The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists |
Q42693785 | The Society for Translational Medicine: clinical practice guidelines for sperm DNA fragmentation testing in male infertility. |
Q38090482 | The azoospermic male: current knowledge and future perspectives |
Q42693487 | The complex nature of the sperm DNA damage process |
Q42693069 | The correct interpretation of sperm DNA fragmentation test. |
Q42693498 | The debate on sperm DNA fragmentation test goes on |
Q42693759 | The importance of quality control and quality assurance in SDF testing |
Q42693183 | The missing piece in management of infertile couple-clinical andrology |
Q37635863 | The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome. |
Q42693588 | The price and value of sperm DNA fragmentation tests |
Q42693378 | The problem of mixing 'apples and oranges' in meta-analytic studies |
Q90846570 | The relationship among sperm global DNA methylation, telomere length, and DNA fragmentation in varicocele: a cross-sectional study of 20 cases |
Q42693387 | The role of female factors in the management of sperm DNA fragmentation. |
Q61798962 | The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis |
Q42693351 | The value of sperm DNA fragmentation testing in real-life clinical presentations. |
Q52242951 | Transurethral resection of partially obstructed ejaculatory ducts: seminal parameters and pregnancy outcomes according to the etiology of obstruction. |
Q58606284 | Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker-The Follicle-To-Oocyte (FOI) Index |
Q42693356 | Understanding sperm DNA fragmentation. |
Q26864911 | Unexplained male infertility: diagnosis and management |
Q42693575 | Unraveling the utility and limitations of clinical practice guidelines. |
Q98727205 | Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept |
Q51542280 | Ureteroscopic stone removal in the distal ureter. Why change? |
Q42693633 | Use of sperm DNA fragmentation testing and testicular sperm for intracytoplasmic sperm injection. |
Q47119377 | Use of testicular sperm for intracytoplasmic sperm injection in men with high sperm DNA fragmentation: a SWOT analysis |
Q89214178 | Use of testicular sperm in nonazoospermic males |
Q42600639 | Varicocele and male infertility: current concepts and future perspectives |